By: Lennard James
Philanthropist and entrepreneur Matt Herman has offered significant support for the final stage of a pivotal research project led by Doman International, the nonprofit at the forefront of neurological rehabilitation for brain-injured children. Herman’s generous contribution will play a key role in completing the important effort to validate the Doman Developmental Profile, a potentially powerful assessment tool that could have a profound impact on clinical practice and help improve outcomes for children affected by brain injuries.
The Doman Developmental Profile is more than a scale—it’s a neurologically driven framework used to evaluate over 40,000 individuals across more than 75 countries. Rooted in neuroplasticity, the method aims to provide targeted home-based therapies and educational programs. The Profile enables caregivers and clinicians to identify neurological deficits and track progress in areas like motor control, speech, cognitive development, and coordination. Thousands of families attribute positive changes to Doman International’s methods, with children walking, speaking, and learning in ways that were previously considered challenging by some medical professionals.
The current Phase 1 research program comparing the Developmental Profile to established tools like the Brunet-Lezine scale has already shown encouraging results. Those initial findings, now accepted in the International Journal on Disability and Human Development, show a notable correlation between the Doman Profile and medical-standard developmental milestones. With only 30–50 more assessments required, the project is nearly complete. The final $25,000 in funding, now underwritten by Matt Herman, will help Doman International bring the study to completion, secure full validation, and share results that could support wider integration into hospitals and clinics around the world.
Upon achieving full validation, the Doman Profile could be licensed to mainstream healthcare institutions, creating both a clinical tool for specialists and a potential revenue stream for Doman to sustain its mission and further expand its global reach. This model aligns with the nonprofit’s goal of creating a self-sustaining cycle where validated research generates ongoing support for families in need.
Matt Herman, best known as the Founder and former CEO of Enhance Health, has focused his efforts on causes that deliver measurable impact, particularly in child development and neurological care. “This research isn’t just validating a tool—it’s providing hope for thousands of families,” he said. Matt Herman’s support aligns with his broader mission to catalyze systemic change through data-supported philanthropic efforts.
Doman International’s founder, Glenn Doman, established the organization over 65 years ago. Since then, the nonprofit has continued to pursue approaches rooted in neuroscience and parent-driven home therapy, earning recognition for its real-world results. Families report progress in communication, movement, and cognition, bringing hope where conventional medicine may not have been as effective.
As the final phase of the study nears completion, the organization is calling on supporters to help meet the last funding targets. Those interested in joining Matt Herman’s effort to validate the Profile can contribute via https://www.domaninternational.org. Contributions will help advance the program’s final steps and assist Doman International in moving into a new phase of growth and increased recognition.
This campaign underscores a key point: when philanthropy intersects with innovation, outcomes can extend beyond expectations. By supporting scientific validation of evidence-based tools, donors like Matt Herman create meaningful and lasting contributions—not only for children and families today but for the future of medicine itself.
The post Matthew Herman Supports Doman International’s Effort to Improve Care for Brain-Injured Children appeared first on Miami Wire.